AllyGPO, an American umbrella of individual specialty group purchasing organisations (GPOs) serving community physician practices, announced on Tuesday the appointment of Ray Bailey, BPharm, RPh as a strategic advisor in the launch of AllyOncology.
In this role, Bailey will support the company in achieving its mission to be an ally in preserving the vitality and value of community oncology care by increasing practices' group purchasing power, productivity and financial health via the management of their oncolytic specialty drugs.
Bailey is an expert in the clinical pharmacy management of cancer patients in the community setting. He served for 14 years at Florida Cancer Specialists & Research Institute (FCS) and established Rx To Go, its in-house oral oncolytic specialty pharmacy. Prior to the oncology practice setting, Bailey spent 24 years in the home infusion specialty pharmacy space.
Dragonfly Therapeutics doses first patient in Phase 1/1b study of DF6215
Ascletis Pharma initiates ASC40 (Denifanstat) Phase III clinical trial to treat acne
Versameb names new chairman of the board
Kling Bio appoints Dr Stefano Gullà as chief scientific officer
ValiRx Plc licenses VAL401 to Ambrose Healthcare for rare disease treatments
ANGLE plc introduces Portrait+ CTC staining kit at San Antonio Breast Cancer Symposium
XNK Therapeutics announces presentation at DNB Nordic Healthcare Conference in Oslo
Syndax to discuss Axatilimab and Revumenib Data Updates at 65th ASH Annual Meeting